DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174695

Correlation of the HPV genotype with the degree of dysplasia in patients with cervicouter cancer in the General Hospital Naval of high specialty

Oyuki A. Morales, Junior J. Araiza, María del R. Garay, Jorge A. Barbabósa, Marlene de la P. Gutiérrez

Abstract


Background: Cervical-uterine cancer (CaCu) is the second leading cause of death in women worldwide and the first in developing countries. It has been correlated to human papillomavirus (HPV) genotype with cancerous lesions reported in histopathological studies, which tells us about the prognosis of the patients. Objective of present study was to correlate the genotype of HPV to the histopathological result evaluated in these patients at the Naval Hospital of High Specialty.

Methods: A total of 316 women attended at the Naval General High Marine Hospital from 2015 to 2016 with HPV diagnosis were included, the histopathological report was correlated with the HPV genotype determined by the chain reaction of the polymerase (PCR). Statistical tests were applied for Smirnov and Kolmogorov, Chi square, OR, Anova-Kruskal Wallis. Data were processed using the SPSS software version 19 and a P <0.05 was taken as statistical significance.

Results: The mean age was 36.0±10.2. The detection of cervical cancer was reported in 3.8% and stage CIN III 2.5%; the highest proportion of patients were in the CIN I stage (51.3%), while the CIN II was 9.2%, and up to 30.7% were classified as HPV infection; only 2.5% were normal. The types of HPV prevalent by PCR were those at high risk different from 16 and 18 with a rate of 34.8%, then 16 at 5.1% and 18 at 0.3%. More than half of the cases (54.4%) were negative for the serotypes analyzed. In general terms, CaCu and CIN III were observed in 15% of the type 16, 0% in type 18, 25% in other high risk and 60% in negative PCR.

Conclusions: In this study, we obtained essential data that tells us that this population could be treated with low-risk HPV types associated with CaCu.


Keywords


Cervical dysplasia, Human papilloma virus, Polymerase chain reaction, Uterine cervical cancer

Full Text:

PDF

References


Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002 cancer incidence. Mortality and prevalence worldwide. IARC Cancer Base no 5, version 2.0, IARC Press, Lyon, France;2004.

Lazcano-Ponce EC, Rascón-Pacheco RA, Lozano-Ascencio R, Velasco-Mondragón HE. Mortality from cervical carcinoma in Mexico: impact of screening, 1980–1990. Acta Cytologica. 1996;40(3):506-12.

Joseph Monsonego, J. Thomas Cox, Catherine Behrens, Maria Sandri, Eduardo L. Franco Poh-Sin Yap, Warner Huh. Prevalence of high risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in large U.S. screening population: data from the ATHENA trial. Gynecol Oncol. 2015;137:47-54.

Salcedo M, Pina-Sanchez P, Vallejo-Ruiz V, Monroy-Garcia A, Aguilar-Lemarroy A, Cortes-Gutierrez EI, et al. Human papillo-mavirus genotypes among females in Mexico: a study from the Mexican Institute for Social Security. Asian Pac J Cancer Prev. 2014;15(23):10061-6.

De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004 Jun 20;324(1):17-27.

Stanley M. Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. Br J Cancer. 2007 May 1;96(9):1320.

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;2003(348):518-27.

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: a meta‐analysis update. Int J Cancer. 2007 Aug 1;121(3):621-32.

Mammas IN, Vageli D, Spandidos DA. Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme. Oncology Reports. 2008 Jul 1;20(1):141-5.

Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005 Sep 23;366(9490):991-8.

Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A, Ponce-de-León S, Mohar A, Maldonado-Rodríguez R et al. Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis. 2010 Dec 31;14(12):e1082-7.

Illades-Aguiar B, del Carmen Alarcón-Romero L, Antonio-Véjar V, Zamudio-López N, Sales-Linares N, Flores-Alfaro E et al. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol. 2010 May 31;117(2):291-6.

Velázquez-Márquez N, Paredes-Tello MA, Pérez-Terrón H, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V. Prevalence of human papillomavirus genotypes in women from a rural region of Puebla, Mexico. Int J Infect Dis. 2009 Nov 30;13(6):690-5.

Illades-Aguiar B, Cortés-Malagón EM, Antonio-Véjar V, Zamudio-López N, del Carmen Alarcón-Romero L, Fernández-Tilapa G, Hernández-Sotelo D, Terán-Porcayo MA, Flores-Alfaro E, Leyva-Vázquez MA. Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors. Cancer Detect Prevent. 2009 Dec 31;32(4):300-7.

Sánchez-Anguiano LF, Alvarado-Esquivel C, Reyes-Romero MA, Carrera-Rodríguez M. Human papillomavirus infections in women seeking cervical Papanicolaou cytology of Durango, Mexico: prevalence and genotypes. BMC Infect Dis. 2006 Feb 20;6(1):27.

Lazcano‐Ponce E, Herrero R, MUnoz N, Cruz A, Shah KV, Alonso P, HERNandez P, SALMERon J, HERNandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001 Feb 1;91(3):412-20.

Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M, Daniel RW, Ghaffari AM, Solorza G, Shah KV. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecologic Oncol. 1998 Jul 31;70(1):115-20.

Peralta-Rodríguez R, Romero-Morelos P, Villegas-Ruíz V, Mendoza-Rodríguez M, Taniguchi-Ponciano K, González-Yebra B, Marrero-Rodríguez D, Salcedo M. Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis. Infect Agents Cancer. 2012 Dec 3;7(1):34.

Ries LAG, Melbert D, Krapcho M. SEER Cancer Statistics Review, 1975-2004. Instituto Nacional del Cáncer; Bethesda, MD;2007.

International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007;120:885.

Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J National Cancer Institute. 2002 Sep 18;94(18):1406-14.

International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006;118:1481.

Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012 Jul 1;120(1):166-72.

Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalitiesa systematic review. Annals Internal Med. 2000 May 16;132(10):810-9.